GARCIA PETER S

Average Profitability
43.32%
Insider Buys Quantity
6
Insider Buys Sum
$254,493.90
Insider Sells Quantity
8
Insider Sells Sum
$6.57M

Insider Activity of GARCIA PETER S

According to the SEC Form 4 filings, GARCIA PETER S, being in a position of

  1. CHIEF FINANCIAL OFFICER at ALX Oncology Holdings Inc.,
    оver the last 12 months, has bought 12000 shares for $102,338, and sold 1893 shares for $28,471,
    over all time since 2020-07-21, has bought 18000 shares for $159,338, and sold 93673 shares for $6.57M.

The largest purchase of all time was on 2024-06-13 and amounted to 12000 shares of ALX Oncology Holdings Inc. for $102,338.

The largest sale of all time was on 2021-08-23 and amounted to 60000 shares of ALX Oncology Holdings Inc. for $4.45M.

Biography of GARCIA PETER S

No biography is available at this moment.

2024-06-13PurchaseALX Oncology Holdings Inc.
ALXO
CHIEF FINANCIAL OFFICER
12,000
0.0229%
$8.53$102,338-77.37%
2023-12-29SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
1,893
0.0038%
$15.04$28,471-37.84%
2023-06-30SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
887
0.0021%
$7.34$6,511+24.9%
2022-12-29SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
893
0.0021%
$11.07$9,886-40.71%
2021-10-18SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
7,229
0.0182%
$55.44$400,793-73.46%
2021-09-17SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
11,345
0.0285%
$78.96$895,811-79.71%
2021-09-16SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
1,426
0.0035%
$80.43$114,695-80.45%
2021-08-23SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
60,000
0.1516%
$74.15$4.45M-76.24%
2021-08-17SaleALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
10,000
0.0239%
$66.23$662,299-74.14%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
Chief Financial Officer
6,000
0.0062%
$9.50$57,000+90.48%
2012-03-19PurchaseEterna Therapeutics Inc.
ERNA
Chief Financial Officer
5,000
0.1071%
$4.68$23,379-9.09%
2012-03-19PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
10,000
0.0199%
$4.68$46,757-10.81%
2011-11-29PurchaseEterna Therapeutics Inc.
ERNA
Chief Financial Officer
2,000
0.0382%
$4.17$8,340-48.78%
2011-11-29PurchaseLineage Cell Therapeutics, Inc.
LCTX
Chief Financial Officer
4,000
0.008%
$4.17$16,680+3.14%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.